Novavax Vs. Sarepta Therapeutics Industry Stock Comparison

Sell

43

NVAX
Novavax

Last Price:

$8.04

Seasonality Move:

19.83%

Buy

55

SRPT
Sarepta Therapeutics

Last Price:

$98.65

Seasonality Move:

6.73%

Sell

43

Novavax (NVAX) is a Sell

Is Novavax a Buy, Sell or Hold?

The current Novavax [NVAX] share price is $8.10. The Score for NVAX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
NVAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

55

Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NVAX Stock Price Chart

What is Novavax's stock price today?

The Novavax share price today is $8.10

The current trend is relatively stagnant and NVAX is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

The Sarepta Therapeutics share price today is $99.77

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

NVAX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.14	Sell
Relative Strength Index (14 RSI):	50.36	Buy
Chaikin Money Flow:	1351181	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(7.63 - 8.37)	Buy
Bollinger Bands (100):	(7.81 - 9.81)	Sell

SRPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-3.4	Sell
Relative Strength Index (14 RSI):	37.2	Sell
Chaikin Money Flow:	-420668	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(103.16 - 112.22)	Sell
Bollinger Bands (100):	(109.63 - 127.19)	Sell

NVAX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	8	Buy
20-day SMA:	7.91	Buy
50-day SMA:	8.45	Sell
200-day SMA:	11.23	Sell
8-day EMA:	7.96	Buy
20-day EMA:	8.02	Buy
50-day EMA:	8.39	Sell
200-day EMA:	9.55	Sell

SRPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	103.49	Sell
20-day SMA:	106.07	Sell
50-day SMA:	113.88	Sell
200-day SMA:	126.52	Sell
8-day EMA:	103.1	Sell
20-day EMA:	106.21	Sell
50-day EMA:	111.8	Sell
200-day EMA:	120.79	Sell

Novavax Earnings Growth & NVAX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.93 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Novavax Technical Analysis

	Feb 26	Feb 27	Feb 28	Mar 3	Mar 4	Mar 5	Mar 6	Mar 7	Mar 11	Mar 12
	Feb				Mar
	26	27	28	03	04	05	06	07	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

	Feb 26	Feb 27	Feb 28	Mar 3	Mar 4	Mar 5	Mar 6	Mar 7	Mar 11	Mar 12
	Feb				Mar
	26	27	28	03	04	05	06	07	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):